CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 133.00
+20.00 (17.70%)
Jul 16, 2026, 2:00 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 24.18 billion as of July 15, 2026. Its market cap has increased by 181.80% in one year.
Market Cap
24.18B
Enterprise Value
22.14B
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
133.00
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has increased from 15.00B to 24.18B, an increase of 61.22%. That is a compound annual growth rate of 5.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 22.26B | 270.11% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.30B |
| Sunmax Biotechnology | 20.75B |
| ACRO Biomedical | 18.30B |
| TaiMed Biologics | 17.84B |
| Ever Supreme Bio Technology | 16.64B |
| Lumosa Therapeutics | 16.15B |
| Medigen Vaccine Biologics | 15.71B |
| TCM Biotech International | 14.70B |